Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of ECT and continuation pharmacotherapy in major depressive disorder
2008-004830-26Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nortriptyline in major depressive disorder (MDD) (2 arms), sponsored by Erasmus MC. Primary endpoints: Treatment phase I mean reduction in HRSD score, Response rate and 2 more. Started Apr 2009; status: completed.
02
Drugs
nortriptyline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2008-004830-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004830-26.